Case Report: IgA Nephropathy in a Patient With Anti-Transcription Intermediary Factor-1γ Antibody-Positive Dermatomyositis

被引:3
|
作者
Zhang, Suo [1 ,2 ]
Chen, Yu-Lan [1 ]
Liu, Cui-Lian [1 ]
Xie, Jing-Yi [1 ]
Sun, Bao-Dong [1 ]
Liu, Dong-Zhou [1 ]
机构
[1] Southern Univ Sci & Technol, Affiliated Hosp 1, Dept Rheumatol & Immunol, Jinan Univ,Clin Med Coll 2,Shenzhen Peoples Hosp, Shenzhen, Peoples R China
[2] Shenzhen Second Peoples Hosp, Dept Rheumatol & Immunol, Shenzhen, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
IgA nephropathy; systemic autoimmune myopathies; dermatomyositis; anti- transcription intermediary factor-1 gamma antibody; dermatomyositis-specific antibodies; RENAL INVOLVEMENT; POLYMYOSITIS; AUTOANTIBODIES; SPECTRUM; GLOMERULONEPHRITIS; CLASSIFICATION; DISEASE; RISK; LOCI;
D O I
10.3389/fimmu.2022.757802
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immunoglobulin A nephropathy (IgAN) is the most common primary glomerulonephritis characterized by IgA deposits in the mesangial area of glomeruli. Connective tissue disorders are some of the most frequent causes of secondary IgAN. Nevertheless, IgAN rarely occurs in systemic autoimmune myopathies (SAMs). The present case study reports on a 58-year-old patient with dermatomyositis with positive anti-transcription intermediary factor (TIF)-1 gamma antibodies who was diagnosed with IgAN during standard immunosuppressive therapy. Moreover, we have made a systematic review regarding the association of SAMs and IgAN. To the best of the authors' knowledge, this is the first case study describing a patient with anti-TIF1 gamma antibody-positive dermatomyositis who developed IgAN, which demonstrates a potential relationship between anti-TIF1 gamma-positive dermatomyositis and IgAN. It is important for clinicians to be aware of the possibility of renal involvement in patients with SAMs, even in those with anti-TIF1 gamma-positive dermatomyositis.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Anti-transcription intermediary factor-1γ/α/β antibody-positive dermatomyositis associated with multiple panniculitis lesions
    Yanaba, Koichi
    Tanito, Katsumi
    Hamaguchi, Yasuhito
    Nakagawa, Hidemi
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2017, 20 (11) : 1831 - 1834
  • [2] Anti-transcription Intermediary Factor1γ-antibody-positive Dermatomyositis Complicated by Dysphagia
    Kurushima, Shota
    Horai, Yoshiro
    Umeda, Masataka
    Kawakami, Atsushi
    INTERNAL MEDICINE, 2017, 56 (21) : 2965 - 2966
  • [4] Triple carcinomas detected in two patients with anti-transcription intermediary factor 1γ (TIF1γ) antibody-positive dermatomyositis
    Shimono, Masahiro
    Koike, Yuta
    Satomi, Naoyoshi
    Morisaki, Hitomi
    Ashida, Miwa
    Murota, Hiroyuki
    EUROPEAN JOURNAL OF DERMATOLOGY, 2022, 32 (02) : 285 - 287
  • [5] Triple carcinomas detected in two patients with anti-transcription intermediary factor 1γ (TIF1γ) antibody-positive dermatomyositis
    Masahiro Shimono
    Yuta Koike
    Naoyoshi Satomi
    Hitomi Morisaki
    Miwa Ashida
    Hiroyuki Murota
    European Journal of Dermatology, 2022, 32 : 285 - 287
  • [6] Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
    Ono, Ryohei
    Kumagae, Tomohiro
    Igasaki, Mari
    Murata, Takaaki
    Yoshizawa, Masaki
    Kitagawa, Izumi
    JOURNAL OF MEDICAL CASE REPORTS, 2021, 15 (01)
  • [7] Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature
    Ryohei Ono
    Tomohiro Kumagae
    Mari Igasaki
    Takaaki Murata
    Masaki Yoshizawa
    Izumi Kitagawa
    Journal of Medical Case Reports, 15
  • [8] Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor
    Ito, Kotaro
    Imafuku, Shinichi
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Nakayama, Juichiro
    JOURNAL OF DERMATOLOGY, 2013, 40 (07): : 567 - 569
  • [9] Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody
    Mizumaki, Kie
    Makino, Satoshi
    Ikawa, Yuka
    Maeda, Shintaro
    Horii, Motoki
    Fushida, Natsumi
    Hamaguchi, Yasuhito
    Nohara, Takahiro
    Izumi, Koji
    Matsushita, Takashi
    JOURNAL OF DERMATOLOGY, 2022, 49 (09): : E311 - E312
  • [10] A case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on "Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-γ antibody"
    Koizumi, Haruka
    Muro, Yoshinao
    Imai, Satoko
    Yamashita, Yuta
    Ogawa-Momohara, Mariko
    Takeichi, Takuya
    Murakami, Megumi
    Mitsuma, Teruyuki
    Akiyama, Masashi
    JOURNAL OF DERMATOLOGY, 2023, 50 (01): : E39 - E40